Stocks to Sell

Stocks can plunge for any number of reasons — investors may need to raise cash for large milestone purchases, or algorithms could be triggered by stop losses which create massive selloffs. Whatever the case, InvestorPlace’s journalists weed out the markets’ losers, keeping you informed of which stocks to cash out of before they come crashing down.

Why Nokia Corp (ADR) (NOK) Stock Needs More Than Innovation to Thrive

Lately, Nokia stock has been doing well off of innovative news. But much of NOK's business still comes from networking equipment, and the market remains awful.

4 Mall REIT Stocks to Avoid as Retail Crash Intensifies (CBL, MAC, PEI, RPT)

Despite an improving economy mall real estate investment trusts has been lackluster. Here are four mall REIT stocks to avoid...

FedEx Corporation (FDX) Stock Is Under Pressure Ahead of Q3 Earnings

FedEx (FDX) reports earnings on March 21, and the Alphabet-esque valuation on FDX stock means shares could get crushed if results disappoint.

General Electric Company (GE): Should Nelson Peltz Just Quit?

Activist Nelson Peltz has little to show for his $2.5 billion investment in General Electric (GE). If it were me, I would bail GE stock.

3 Reasons Fitbit Inc (FIT) Stock Isn’t Going Anywhere But Down

Fitbit stock is an extremely risky play due to the firm’s weak business model, failure to cope with competition and crumbling financials.

What Apple Inc. (AAPL) Stock Needs to Make ANY Waves From Here

Apple (AAPL) should be unleashing new iPads soon, but AAPL stock will need much, much more than that to keep pushing north.

Don’t Expect a Ford Motor Company (F) Stock Turnaround Anytime Soon

Ford stock has been spinning its wheels for years. Even at bargain valuations, there are no signs of a turnaround in sight for F stock.

Chesapeake Energy Corporation (CHK) Stock Is a Zombie You Need to Avoid

CHK stock is now worth more than its assets, when its debt is taken into account. Yet Chesapeake Energy directors still buy it, and smart institutions still hold it.

Layoffs or Not, GoPro Inc (GPRO) Stock Is Losing an Uphill Battle

GoPro (GPRO) popped 11% on news of cost cuts that could lead it to profitability, but GPRO stock remains in more trouble than it can handle.

3 Growth Stocks That Are No Longer Growing

When looking for reasons to drop growth stocks, look for signs like lowered guidance and the end of revenue and earnings streaks.

4 High-Yield Dividend Stocks You Should Pass Up

OXY, FTR, MAT and SPLS may look like great high-yield dividend stocks, but they're struggling against some major headwind. Stay away!

Sell the Bounce In Sears Holding Corp (SHLD) Stock

Sears (SHLD) has posted some gains of late, but the optimism will be short-lived. There's too much debt, and too few assets, to go long SHLD.

Why Rite Aid Corporation (RAD) Stock Isn’t a “Bargain Trade”

Some investors are licking their chops over the 40% drubbing RAD stock has suffered this year. Make no mistake though -- a Walgreens deal is the only upside Rite Aid has here.

5 Airline Stocks That Are Losing Altitude FAST

Southwest Airlines (LUV) and American Airlines (AAL) are among the five airline stocks that are in trouble.

Take Jeffries’ Netflix, Inc. (NFLX) Upgrade With a Grain of Salt

Another analyst turned more optimistic on Netflix (NFLX), But the growing crowd of bulls hasn't answered this question facing NFLX stock.

Is Snap Inc (SNAP) Stock Suffering From an Identity Crisis?

Snap Inc appears to have had an identity crisis, as SNAP is calling itself a camera company despite the fact that it has only released one camera.

Vivint Solar Inc (VSLR): Is This the End for Residential Solar?

Vivint Solar (VSLR) is on the wrong side of the solar energy trade. Its solar leasing model is stale, and so is VSLR stock.

75 Household Names To Sell Right Away

As we approach the end of the first quarter, now is an excellent time to trim your portfolio of all dead weight. Here's where to start

3 Pharmacy Stocks at Risk Due to Skyrocketing Drug Costs

Initially buoyed by promises of lower regulations, pharmacy stocks now face a new threat -- anger towards rising drug costs.